Terms: = Skin cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Clinical Outcome
3 results:
1. clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis.
Varey AHR; Williams GJ; Lo SN; Taing CY; Maurichi A; Santinami M; Scolyer RA; Thompson JF
J Eur Acad Dermatol Venereol; 2023 May; 37(5):859-870. PubMed ID: 36251355
[TBL] [Abstract] [Full Text] [Related]
2. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract] [Full Text] [Related]
3. What is CD4+CD56+ malignancy and how should it be treated?
Reimer P; Rüdiger T; Kraemer D; Kunzmann V; Weissinger F; Zettl A; Konrad Müller-Hermelink H; Wilhelm M
Bone Marrow Transplant; 2003 Oct; 32(7):637-46. PubMed ID: 13130309
[TBL] [Abstract] [Full Text] [Related]